ARQ Genetics
Private Company
Total funding raised: $2.5M
Overview
ARQ Genetics is a specialized contract research organization (CRO) providing custom qPCR and gene expression services to the research community. Founded in 2018 and based in Bastrop, Texas, the company differentiates itself through a flexible, client-driven approach with no minimum order requirements and a staff composed entirely of Ph.D. scientists. Its business model is built on offering researchers a cost-effective alternative to establishing in-house qPCR capabilities, with a strong track record evidenced by client publications in peer-reviewed journals. The company appears to be a privately-held, revenue-generating services business.
Technology Platform
Service platform for custom qPCR/RT-PCR gene expression analysis, leveraging Ph.D.-level scientific expertise, custom assay design, and a full workflow from RNA isolation to data delivery.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
ARQ Genetics competes in the qPCR services market against large, diversified CROs (e.g., LabCorp, Charles River), university core facilities, and other niche service providers. Its key differentiators are its fully Ph.D. staff, extreme customization flexibility with no minimum orders, and a focus on publication-quality data for targeted gene expression studies.